Scorr-Insert
X

Find Clinical Drug Pipeline Developments & Deals by Inotrem S.A

A collaboration with SCORR Marketing

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Contact the Supplier

Lead Product(s): Antibodies

Therapeutic Area: Immunology

Highest Development Status: Discovery Product Type: Large molecule

Recepient: Iontas

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Collaboration May 07, 2020

Details:

As part of the agreement, IONTAS will apply its Mammalian Display technology to identify antibodies involved in the TREM-1 pathway.

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Contact the Supplier

Lead Product(s): Nangibotide

Therapeutic Area: Trauma (Emergency, Injury, Surgery)

Highest Development Status: Phase II Product Type: Large molecule

Partner/Sponsor/Collaborator: Roche Diagnostics GmbH

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Licensing Agreement January 21, 2020

Details:

Inotrem entered a worldwide licensing agreement with Roche Diagnostics for the commercialization of a mechanism-based companion diagnostic test using a soluble plasma protein.